Nusantara Almazia Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Nusantara Almazia Tbk. trades at Rp135 (market cap 303.26B, 3.71M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume). The key difference: Prodia Diagnostic Line Tbk is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 3.71M). Which is the better fit depends on your goals.
| NZIA | PRDL | |
|---|---|---|
Market Cap | 303.26B | 470.58B |
Volume | 3.71M | 18.86M |
Lot | 37.09K | 188.57K |
Turnover | 502.68M | 4.97B |
Average Price | 135.53 | 263.63 |
Value | 502.68M | 4.97B |
Indicative Equilibrium Price | 135 | 264 |
Indicative Equilibrium Volume | 1.74K | 3.64K |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusantara Almazia Tbk (the "Company") was incorporated under Deed No. 24 dated November 26, 2007 made by Ukon Krisnajaya, S.H., S.Pn,.
Read more on NZIA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →